SCHEMBL15940334

SCHEMBL15940334

Cc1nc(CC(N)=O)sc1-c1csc(Nc2cccc(-c3nnc(N)s3)c2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.55
KMT2A Q03164 9/20 0.55
POLB P06746 3/20 0.55
GAA P10253 3/20 0.55
TDP1 Q9NUW8 2/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
NPC1 O15118 4/20 0.54
PIK3CG P48736 2/20 0.51
RAB9A P51151 5/20 0.50
MAPT P10636 4/20 0.50
USP2 O75604 2/20 0.50
MAPK1 P28482 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HSD17B10 Q99714 2/20 0.50
TSHR P16473 1/20 0.50
CFTR P13569 1/20 0.49
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 1/20 0.49
ALOX15 P16050 1/20 0.49
CLK1 P49759 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4520112 0.85 PIK3CG (0.70) MEN1KMT2APOLBGAATDP1
SCHEMBL15940286 0.84 MEN1 (0.51) MEN1KMT2APOLBGAATDP1
SCHEMBL15940236 0.82 MEN1 (0.50) MEN1KMT2APOLBGAATDP1
SCHEMBL15940390 0.75 MEN1 (0.53) MEN1KMT2APOLBGAATDP1
SCHEMBL2835239 0.74 PIK3CG (0.64) MEN1KMT2APOLBGAATDP1
SCHEMBL2835750 0.73 PIK3CG (0.54) MEN1KMT2APOLBGAATDP1
SCHEMBL14146881 0.72 MEN1 (0.86) MEN1KMT2APOLBGAATDP1
Bromide SCHEMBL14053834 0.72 MEN1 (0.84) MEN1KMT2APOLBGAATDP1
SCHEMBL15940392 0.71 MAPT (0.55) MEN1KMT2APOLBGAATDP1
SCHEMBL16434487 0.71 MEN1 (0.80) MEN1KMT2APOLBGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF MERCK SERONO S.A. (CH) 2014-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF PF4, TEC, PDGFRB MEN1 1164/4885KMT2A 4760/4885POLB 3839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.